Superstring Capital Management LP Bridge Bio Pharma, Inc. Transaction History
Superstring Capital Management LP
- $84.5 Billion
- Q2 2025
A detailed history of Superstring Capital Management LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Superstring Capital Management LP holds 96,766 shares of BBIO stock, worth $5.94 Million. This represents 4.95% of its overall portfolio holdings.
Number of Shares
96,766
Previous 183,922
47.39%
Holding current value
$5.94 Million
Previous $6.36 Billion
34.28%
% of portfolio
4.95%
Previous 7.56%
Shares
7 transactions
Others Institutions Holding BBIO
# of Institutions
414Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.14 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.01 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$814 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$764 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$569 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.1B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...